Silencing circular ANRIL protects HK-2 cells from lipopolysaccharide-induced inflammatory injury through up-regulating microRNA-9
Source abstract
Abstract
Circular antisense non-coding RNA in the INK4 locus (cANRIL) participated in inflammation of endothelial cells. However, whether cANRIL is associated with inflammatory injury of HK-2 cells, thereby affecting chronic kidney disease has not been investigated. We tested the hypothesis that cANRIL participated in inflammatory response in vitro. HK-2 cells were stimulated by lipopolysaccharides (LPS). RT-qPCR was executed for cANRIL expression assessment. After transfection, cell viability, apoptosis, inflammatory cytokines and ROS generation were appraised to evaluate the impact of silencing cANRIL on LPS-induced inflammatory injury. The regulatory relationship between cANRIL and microRNA-9 (miR-9) was verified. In addition, whether miR-9 affected LPS-induced inflammatory injury was measured after miR-9 inhibitor transfection. Western blot was utilized to detect NF-κB and JNK/p38 pathway-related proteins. The results showed that LPS promoted cANRIL expression and cell injuries in HK-2 cells. Furthermore, silencing cANRIL alleviated inflammatory injuries by promoting viability, suppressing apoptosis, inflammatory cytokines and ROS generation in HK-2 cells. In addition, miR-9 expression was accelerated by silencing cANRIL. Meanwhile, miR-9 down-regulation invalidated the effect of silencing cANRIL on inflammation and NF-κB and JNK/p38 pathways. The study clarified that silencing cANRIL hindered NF-κB and JNK/p38 pathways by positively regulating miR-9, thereby protecting HK-2 cells from LPS-induced injury.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Cancer-related molecular mechanisms research · Circular RNAs in diseases · MicroRNA in disease regulation
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Nephrology, Jining No.1 People’s Hospital
References (40)
Show source-provided references
1. 10.1016/j.amjmed.2015.08.02510.1016/j.amjmed.2015.08.025 ↗
2. 10.1016/S0140-6736(13)60687-X10.1016/S0140-6736(13)60687-X ↗
3. 10.1016/j.semnephrol.2016.05.00510.1016/j.semnephrol.2016.05.005 ↗
4. 10.1016/j.kint.2016.09.01510.1016/j.kint.2016.09.015 ↗
5. 10.1016/j.kint.2016.09.04910.1016/j.kint.2016.09.049 ↗
6. 10.1681/ASN.201411106310.1681/ASN.2014111063 ↗
7. 10.1177/107424841350499410.1177/1074248413504994 ↗
8. 10.1155/2018/870237210.1155/2018/8702372 ↗
9. 10.1177/153537021770897810.1177/1535370217708978 ↗
10. 10.1080/15476286.2016.127152410.1080/15476286.2016.1271524 ↗
11. 10.3389/fendo.2018.0040510.3389/fendo.2018.00405 ↗
12. Chi JS, Li JZ, Jia JJ, et al. Long non-coding RNA ANRIL in gene regulation and its duality in atherosclerosis. J Huazhong Univ Sci Technol Med Sci. 2017;37(6):816–822.
13. 10.1371/journal.pgen.100123310.1371/journal.pgen.1001233 ↗
14. 10.1038/ncomms1242910.1038/ncomms12429 ↗
15. 10.1159/00047891810.1159/000478918 ↗
16. 10.1152/ajprenal.00569.201610.1152/ajprenal.00569.2016 ↗
17. 10.1152/ajprenal.00523.201510.1152/ajprenal.00523.2015 ↗
18. 10.1016/j.bone.2016.11.01610.1016/j.bone.2016.11.016 ↗
19. 10.1016/j.ejphar.2019.02.01510.1016/j.ejphar.2019.02.015 ↗
20. Chen LL, Xu Y. Epigallocatechin gallate attenuates uric acid-induced injury in rat renal interstitial fibroblasts NRK-49F by up-regulation of miR-9. Eur Rev Med Pharmacol Sci. 2018;22:7458–7469.
21. 10.1006/meth.2001.126210.1006/meth.2001.1262 ↗
22. 10.3390/molecules2210168310.3390/molecules22101683 ↗
23. 10.1159/00047082210.1159/000470822 ↗
24. 10.1080/15548627.2017.130948510.1080/15548627.2017.1309485 ↗
25. 10.1038/s41581-019-0158-z10.1038/s41581-019-0158-z ↗
26. 10.2353/ajpath.2010.09051710.2353/ajpath.2010.090517 ↗
27. 10.1016/j.nephro.2016.02.00510.1016/j.nephro.2016.02.005 ↗
28. Wang Y, Zhang W, Yu G, et al. Cytoprotective effect of aquaporin 1 against lipopolysaccharide-induced apoptosis and inflammation of renal epithelial HK-2 cells. Exp Ther Med. 2018;15:4243–4252.
29. 10.1016/j.bbrc.2009.06.06310.1016/j.bbrc.2009.06.063 ↗
30. 10.1016/j.omtn.2018.11.01410.1016/j.omtn.2018.11.014 ↗
31. 10.1016/j.ymthe.2019.01.00610.1016/j.ymthe.2019.01.006 ↗
32. 10.1093/toxsci/kfz07410.1093/toxsci/kfz074 ↗
33. 10.1016/j.cell.2011.07.01410.1016/j.cell.2011.07.014 ↗
34. 10.1152/ajpcell.00122.201510.1152/ajpcell.00122.2015 ↗
35. 10.1038/nrm208310.1038/nrm2083 ↗
36. 10.1155/2019/785086310.1155/2019/7850863 ↗
37. 10.1016/j.bbadis.2019.05.01010.1016/j.bbadis.2019.05.010 ↗
38. 10.1016/j.gene.2019.05.01210.1016/j.gene.2019.05.012 ↗
39. 10.1016/j.bbrc.2019.02.08210.1016/j.bbrc.2019.02.082 ↗
40. 10.1111/asj.1310810.1111/asj.13108 ↗